RESUMO
OBJECTIVE: Depressive and anxiety symptoms are associated with Ischemic Heart Disease (IHD). Exercise interventions might improve both depressive and anxiety symptoms, but an overview of the evidence is lacking. Therefore, we systematically reviewed the existing literature on the effectiveness of exercise therapy to reduce depression and anxiety symptoms specifically in patients with IHD. METHODS: MEDLINE, EMBASE, PsycINFO and the Cochrane Central Register of Controlled Trials were searched until January 2016. The effectiveness of exercise was assessed within two groups: a) patients selected for study with severe depression or anxiety; and b) studies that did not exclusively targeted patients with increased levels of depression or anxiety. Secondary outcomes were mortality, cardiac events, re-hospitalizations and cardiovascular risk factors. RESULTS: We included fourteen studies. Clinical and methodological heterogeneity precluded meta-analysis. Three studies specifically included patients with high levels of depression or anxiety and eleven studies selected patients with unclear levels of depression or anxiety. Some RCTs showed that exercise was effective in lowering severe depressive symptoms (short and long term follow-up), but for the group with unclear depressive symptoms the results were non-conclusive. In the group with elevated anxiety symptoms, exercise had a positive effect on the short term follow-up. In the group with unclear anxiety symptoms the results were inconsistent (short and long term follow-up). No differences were found regarding the secondary outcomes. CONCLUSIONS: There is a general paucity of data on the effect of exercise, precluding firm conclusions about the effectiveness of exercise for depressive and anxiety symptoms in IHD patients.
Assuntos
Ansiedade/terapia , Depressão/terapia , Terapia por Exercício/psicologia , Isquemia Miocárdica/terapia , Adulto , Idoso , Ansiedade/etiologia , Ensaios Clínicos como Assunto , Depressão/etiologia , Terapia por Exercício/métodos , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/psicologia , Resultado do TratamentoRESUMO
PURPOSE: To investigate cardiovascular nurses' experiences of and attitudes towards the presence of family members during resuscitation of adult patients. METHODS: A 36-item questionnaire exploring the experiences of and attitudes towards family members being present in the resuscitation room was distributed to a convenience sample of nurses attending three national and one international cardiovascular nursing conferences held in Europe during 2007. RESULTS: Of 820 questionnaires distributed, 411(50%) completed ones were returned. Of these 411 respondents, 178 (44%) had experienced at least one situation of families being present. Positive (23%) and negative (21%) experiences of family presence were equally distributed. Only 28 (7%) respondents stated that their unit had a protocol covering family presence. Nurses in Ireland (n=30; 59%) and the UK (n=18; 55%) were most likely to have experienced family presence and protocols relating to this were most commonly found in the UK (n=4; 14%). CONCLUSION: Less than half of the included European cardiovascular nurses had experienced a situation of families being present during resuscitation and protocols pertaining to this were rare. There was no clear attitude towards family presence, though experience in nursing made nurses more favourable towards it.
Assuntos
Atitude do Pessoal de Saúde , Reanimação Cardiopulmonar/enfermagem , Reanimação Cardiopulmonar/psicologia , Enfermagem Familiar/psicologia , Família/psicologia , Recursos Humanos de Enfermagem Hospitalar/psicologia , Adulto , Tomada de Decisões , Europa (Continente) , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Visitas a Pacientes/psicologiaRESUMO
BACKGROUND: Previous studies have shown that smoking cessation after a cardiac event reduces the risk of subsequent mortality in patients, but the effect of smoking cessation in terms of prolonged life-years is not yet known. METHODS: We analyzed the 30-year clinical outcome of the first 1,041 consecutive patients (age at operation 51 years, 92% male) who successfully underwent isolated venous coronary artery bypass surgery between 1971 and 1980. All 551 smokers (53%) were included in this study. Of these, 43% stopped smoking throughout the first year whereas 57% persisted smoking. RESULTS: The median follow-up was 29 years (range 26-36 years). The cumulative 10-, 20-, and 30-year survival rates were 88%, 49%, and 19%, respectively, in the group of patients who quit smoking, and only 77%, 36%, and 11%, respectively, in the persistent smokers (P < .0001). After adjusting for all baseline characteristics, smoking cessation remained an independent predictor of lower mortality (hazard ratio 0.60, 95% CI 0.48-0.72). We were able to assess the exact life expectancy by calculating the area under the Kaplan-Meier curves. Life expectancy in the quitters was 20.0 years and 17.0 years in the persistent smokers (P < .0001). CONCLUSIONS: Using 30-year follow-up data, we estimated that self-reported smoking cessation after coronary artery bypass surgery was associated with a life expectancy gain of 3 years. Smoking cessation turned out to have a greater effect on reducing the risk of mortality than the effect of any other intervention or treatment.
Assuntos
Ponte de Artéria Coronária , Expectativa de Vida , Abandono do Hábito de Fumar , Ponte de Artéria Coronária/mortalidade , Feminino , Seguimentos , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório , Modelos de Riscos ProporcionaisAssuntos
Fármacos Cardiovasculares/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Promoção da Saúde , Hipoglicemiantes/uso terapêutico , Hipolipemiantes/uso terapêutico , Prevenção Primária/normas , Pressão Sanguínea/efeitos dos fármacos , Fármacos Cardiovasculares/farmacologia , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/genética , Doenças Cardiovasculares/fisiopatologia , Diabetes Mellitus/sangue , Diabetes Mellitus/tratamento farmacológico , Dislipidemias/sangue , Dislipidemias/complicações , Dislipidemias/tratamento farmacológico , Europa (Continente) , Feminino , Predisposição Genética para Doença , Fidelidade a Diretrizes , Frequência Cardíaca/efeitos dos fármacos , Humanos , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Hipertensão/fisiopatologia , Inflamação/sangue , Inflamação/complicações , Nefropatias/complicações , Nefropatias/terapia , Estilo de Vida , Lipídeos/sangue , Masculino , Síndrome Metabólica/complicações , Síndrome Metabólica/tratamento farmacológico , Síndrome Metabólica/fisiopatologia , Atividade Motora , Fenômenos Fisiológicos da Nutrição , Obesidade/complicações , Obesidade/fisiopatologia , Obesidade/terapia , Sobrepeso , Medição de Risco , Fatores de Risco , Fatores Sexuais , Fumar/efeitos adversos , Abandono do Hábito de Fumar , Estresse Psicológico/complicações , Estresse Psicológico/terapia , Resultado do TratamentoAssuntos
Fármacos Cardiovasculares/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Promoção da Saúde , Hipoglicemiantes/uso terapêutico , Hipolipemiantes/uso terapêutico , Prevenção Primária/normas , Pressão Sanguínea/efeitos dos fármacos , Fármacos Cardiovasculares/farmacologia , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/genética , Doenças Cardiovasculares/fisiopatologia , Diabetes Mellitus/sangue , Diabetes Mellitus/tratamento farmacológico , Dislipidemias/sangue , Dislipidemias/complicações , Dislipidemias/tratamento farmacológico , Feminino , Predisposição Genética para Doença , Fidelidade a Diretrizes , Frequência Cardíaca/efeitos dos fármacos , Humanos , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Hipertensão/fisiopatologia , Inflamação/sangue , Inflamação/complicações , Nefropatias/complicações , Nefropatias/terapia , Estilo de Vida , Lipídeos/sangue , Masculino , Síndrome Metabólica/complicações , Síndrome Metabólica/tratamento farmacológico , Síndrome Metabólica/fisiopatologia , Atividade Motora , Fenômenos Fisiológicos da Nutrição , Obesidade/complicações , Obesidade/fisiopatologia , Obesidade/terapia , Sobrepeso , Medição de Risco , Fatores de Risco , Fatores Sexuais , Fumar/efeitos adversos , Abandono do Hábito de Fumar , Estresse Psicológico/complicações , Estresse Psicológico/terapia , Resultado do TratamentoRESUMO
BACKGROUND: From a previous survey of cardiac nurses attending a scientific conference, we learned that these nurses adopted a healthier lifestyle than the general population. AIMS: The aim of this study was to determine the overall profile of cardiac risk factors in a similar cohort and determine whether cardiac nurses continue to 'practice what they preach' in this regard. Secondly, we examined the practical value of screening a large cohort of individuals within a short time frame (total of 8 hours screening time) and determined the range of BNP concentrations within a 'healthy' cohort. METHODS: Data on CHD risk factors were collected with a short self-report questionnaire. The sample consisted of 122 cardiac nurses from 19 countries attending a European cardiac nursing conference held in Stockholm. A venous blood sample was collected into a tube containing potassium ETDA. B-type natriuretic peptide was measured on-site with the use of a portable fluorescence immunoassay kit. RESULTS: Most participants were female (89%). Participants ranged in age from 23 to 60 years with a mean age of 41 (S.D. 9.4). Eleven percent - all female - reported they were current smokers, 27% (34) had a BMI >25 and 27% of the sample stated they did not exercise regularly. Almost half (48%) of the sample reported a family history of CHD. As expected, all BNP-values were within the normal range. There were significant differences in BNP on the basis of sex (P<0.05) and age (P<0.05) and a trend towards increasing BNP concentrations with progressively higher BMI scores (P=0.06). CONCLUSION: This study reconfirms the likelihood that many cardiac nurses heed their own advice on lifestyle modification to reduce cardiovascular risk and therefore provide a good role model for the promotion of primary and secondary prevention initiatives.
Assuntos
Cardiologia , Doença das Coronárias/sangue , Doença das Coronárias/etiologia , Peptídeo Natriurético Encefálico/sangue , Enfermeiros Clínicos , Adulto , Atitude Frente a Saúde , Doença das Coronárias/epidemiologia , Doença das Coronárias/prevenção & controle , Complicações do Diabetes , Europa (Continente)/epidemiologia , Feminino , Imunoensaio de Fluorescência por Polarização , Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Inquéritos Epidemiológicos , Humanos , Hipertensão/complicações , Estilo de Vida , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Enfermeiros Clínicos/educação , Enfermeiros Clínicos/psicologia , Enfermeiros Clínicos/estatística & dados numéricos , Obesidade/complicações , Medição de Risco/métodos , Fatores de RiscoRESUMO
BACKGROUND: Having a leg ulcer has a major impact on daily life. Lifestyle is mentioned in most leg ulcer guidelines but mostly without much emphasis on the subject. AIMS AND OBJECTIVES: Evidence for the effect of nutrition, leg elevation and exercise on the healing of leg ulcers was reconsidered. Furthermore, the evidence for effective pain-related interventions was investigated. DESIGN: Systematic literature review. METHODS: Medline, Cinahl, Psychinfo and Cochrane were searched for studies on pain related interventions, and the effectiveness of leg elevation, leg exercise and nutritional interventions in patients with venous leg ulceration. RESULTS: Some evidence was found to support a positive effect of leg exercises on the endurance and power of the calf muscle and on the haemodynamic status of the limb. There is also evidence for a positive effect of leg elevation during bed rest without compression. No hard evidence was found concerning the effect of enriched or altered nutrition on wound healing. However, there is some evidence of nutritional deficits in this patient group. The use of eutectic mixture of local anaesthetic cream is effective for reducing pain in wound debridement, but pain relief in daily life is insufficiently treated. CONCLUSION: There is no real evidence of effectiveness of the investigated lifestyle interventions but there are indications that lifestyle interventions might contribute to healing or prevention of venous leg ulceration. RELEVANCE TO CLINICAL PRACTICE: Although there is no hard evidence, it can be expected that interventions such as nutritional monitoring, guided exercise and leg elevation will have a substantial impact on wound healing in patients with venous leg ulceration. The use of eutectic mixture of local anaesthetic cream can be advised for pain relief with wound debridement. The current lack of effective pain treatment with venous leg ulceration emphasizes the need for effective pain treatment.